Millennium Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.78M | Buy |
2,935,728
+1,163,074
| +66% | +$2.69M | ﹤0.01% | 1871 |
|
|
2025
Q1 | $2.46M | Buy |
1,772,654
+1,621,040
| +1,069% | +$2.25M | ﹤0.01% | 2459 |
|
|
2024
Q4 | $262K | Buy |
+151,614
| New | +$262K | ﹤0.01% | 3558 |
|
|
2024
Q3 | – | Sell |
-340,724
| Closed | -$763K | – | 4472 |
|
|
2024
Q2 | $763K | Sell |
340,724
-2,794,593
| -89% | -$6.26M | ﹤0.01% | 3009 |
|
|
2024
Q1 | $9M | Sell |
3,135,317
-245,215
| -7% | -$704K | ﹤0.01% | 1570 |
|
|
2023
Q4 | $5.98M | Buy |
+3,380,532
| New | +$5.98M | ﹤0.01% | 1793 |
|
|
2023
Q3 | – | Sell |
-614,938
| Closed | -$406K | – | 4593 |
|
|
2023
Q2 | $406K | Buy |
614,938
+137,893
| +29% | +$91.1K | ﹤0.01% | 3376 |
|
|
2023
Q1 | $380K | Buy |
477,045
+90,456
| +23% | +$72.1K | ﹤0.01% | 3550 |
|
|
2022
Q4 | $874K | Buy |
386,589
+212,211
| +122% | +$480K | ﹤0.01% | 3270 |
|
|
2022
Q3 | $337K | Sell |
174,378
-41,790
| -19% | -$80.8K | ﹤0.01% | 4114 |
|
|
2022
Q2 | $804K | Buy |
+216,168
| New | +$804K | ﹤0.01% | 3584 |
|
|
2022
Q1 | – | Sell |
-60,049
| Closed | -$700K | – | 5651 |
|
|
2021
Q4 | $700K | Buy |
+60,049
| New | +$700K | ﹤0.01% | 3756 |
|
|
2021
Q3 | – | Sell |
-30,165
| Closed | -$639K | – | 5476 |
|
|
2021
Q2 | $639K | Buy |
30,165
+9,040
| +43% | +$191K | ﹤0.01% | 4023 |
|
|
2021
Q1 | $429K | Buy |
21,125
+1,725
| +9% | +$35K | ﹤0.01% | 3742 |
|
|
2020
Q4 | $515K | Sell |
19,400
-153,857
| -89% | -$4.08M | ﹤0.01% | 3219 |
|
|
2020
Q3 | $3.88K | Buy |
+173,257
| New | +$3.88K | ﹤0.01% | 1605 |
|